Novavax (NVAX) Cuts Full-Year Forecast as Vaccine Sales Decline
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Novavax (NVAX) Misses Q2 EPS by $12.03, Cuts FY Guidance
August 8, 2022 4:07 PM EDTNovavax (NASDAQ: NVAX) reported Q2 EPS of ($6.53), $12.03 worse than the analyst estimate of $5.50. Revenue for the quarter came in at $186 billion versus the consensus estimate of $1.02 billion.
GUIDANCE:
Novavax sees FY2022 revenue of $2-2.3 billion, versus the consensus of $4.27... More
Novavax (NVAX) Halted, News Pending
August 8, 2022 4:01 PM EDTNovavax (NASDAQ: NVAX) Halted, News Pending
... MoreU.S. administers over 7,300 Novavax vaccine doses - CDC
August 5, 2022 11:25 AM EDT(Reuters) - The United States has administered more than 7,300 doses of Novavax Inc's COVID-19 shot, which health officials hope will convince more people to opt for vaccinations as it is based on a technology that has been in use for decades.
Over 330,000 doses of Novavax's COVID-19 vaccine have been... More
Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years
August 4, 2022 9:04 AM EDTNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the initiation of its Phase 2b/3 Hummingbird global clinical trial. The trial will evaluate the safety, effectiveness (immunogenicity), and efficacy of two doses of the Novavax COVID-19 vaccine (NVX-CoV2373) in younger... More
